Skip to content

The Effect of Antenatal Corticosteroid on Umbilical Artery Doppler Velocimetry in IUGR

The Effect of Antenatal Corticosteroid Administration on Umbilical Artery Doppler Velocimetry in Pregnant Women Complicated With IUGR

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05588986
Enrollment
149
Registered
2022-10-20
Start date
2018-02-02
Completion date
2019-02-02
Last updated
2023-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine Growth Restriction

Brief summary

The purpose of this study is to evaluate the effect of antenatal corticosteroid administration on umbilical artery Doppler velocimetry measurements in pregnancies complicated by IUGR.

Detailed description

This study was conducted with pregnant women who were likely to have preterm birth and were treated with antenatal corticosteroids. Betamethasone was used as an antenatal corticosteroid. UA Doppler measurements (PI, S/D ratio, RI) before antenatal corticosteroid administration and 24 and 48 hours after the last dose of corticosteroid administration were evaluated in pregnant groups complicated with IUGR and uncomplicated with IUGR and compared with each other.

Interventions

OTHERultrasonography

Umbilical artery Doppler evaluation by ultrasonography just before the first dose of antenatal corticosteroid, 24 hours and 48 hours after the last dose.

Sponsors

Marmara University
CollaboratorOTHER
Merve Demir
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 49 Years

Inclusion criteria

pregnant women who were likely to have preterm delivery and were treated with antenatal corticosteroids.

Exclusion criteria

Pregnant women who had complicated pregnancy with fetal anomaly, who had multiple pregnancies, who left their pregnancy follow-up unfinished, and those under 18 years of age were excluded from the study.

Design outcomes

Primary

MeasureTime frameDescription
systolic:diastolic ratio (S/D ratio)2018-2019Peak systolic velocity/end diastolic velocity
pulsatility index (PI)2018-2019Pulsatility Index (PI) = (Peak systolic velocity - end diastolic velocity)/(time averaged maximum velocity)
Resistive Index (RI)2018-2019Resistive Index (RI) = (Peak systolic velocity - end diastolic velocity)/(peak systolic velocity)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026